FemTech is a sector that is growing, and fast. As of September 2022, the total funding to the FemTech sector in the UK was over $740 million according to Deep Knowledge Group.
This makes it an incredibly interesting sector to keep an eye on, especially as tech starts to help women navigate areas of their health and wellbeing that were previously ignored.
What Does FemTech Cover?
FemTech, short for “female technology” is used to describe products, services and apps designed specifically for women’s health and wellness. Typically, this covers things like:
- Menstrual health, including period tracking apps and devices, sustainable menstrual products and smart devices that can help with pain management.
- Pregnancy planning, including at home hormone testing, fertility trackers and products to help the body have the right vitamins it needs during this time.
- Sexual health, including easier STD testing, libido tracking and tech-driven contraceptive options.
- Support with menopause, which includes devices to help with symptoms, symptom trackers and online therapy for any emotional elements.
- Support with mental wellbeing, such as therapists specifically for women, vitamins and mental health trackers.
To help us figure out what 2025 might have in store for this sector, we asked the experts. Here’s what they had to say..
Our Experts
- Valentina Milanova, Founder & CEO of Daye
- Mayra Hurtado, CEO of Hormony
- Kanika Mishra Pathak, Lead R&D Director at MHA
- Jennifer Pfau, FemTech Advocate and CEO at pFocus Marketing
- Caroline MacDonald, Founder & CEO of Oggadoon
Valentina Milanova, Founder & CEO of Daye
“As we look ahead to 2025, I believe femtech will play a crucial role in advancing women’s health and closing critical care gaps. At Daye, we’re particularly focused on supporting the NHS’s goal of eradicating cervical cancer by 2040 through our non-invasive, at-home HPV screening solution. This technology will make regular screening more accessible and convenient, helping to detect high-risk HPV infections early and reducing the incidence of cervical cancer.
“Beyond cervical health, I predict we’ll see a surge in personalised, tech-enabled care solutions addressing historically underserved areas of vaginal, menstrual and hormonal health. Daye’s virtual nurse and OBGYN consultations aim to support the 700,000 women currently on gynaecological health waiting lists in the UK.
“Importantly, increased investment in femtech could yield significant economic benefits. Research shows that for every additional £1 invested in obstetrics and gynaecology services per patient in England, there’s a potential £11 return. By 2025, I expect we’ll see more recognition of how supporting female health drives broader societal and economic gains.
“Ultimately, femtech in 2025 will be about leveraging technology to provide more accessible, personalised care while simultaneously addressing systemic gaps in women’s healthcare.”
Mayra Hurtado, CEO of Hormony
“In 2025, femtech will continue on its trajectory as a transformative force in the global economy: reshaping industries, boosting workforce efficiency, and creating entirely new markets. Beyond its projected $60 billion market valuation, femtech’s innovations will catalyse growth in biotechnology, wearable technology, and AI-driven preventive healthcare, leading to cascading economic benefits across sectors.
“The integration of real-time biometric monitoring through wearable devices, paired with AI that can predict and prevent health crises, will drastically reduce the economic burden of untreated women’s health conditions. For instance, precision care in areas like endometriosis and reproductive health could save billions annually in healthcare costs while increasing workforce participation. It’s likely that Governments will recognise femtech solutions in public health policies, creating massive procurement opportunities and driving down healthcare disparities, whilst relieving pressure on healthcare services.
“As femtech products become more ubiquitous and accessible, global supply chains will be reshaped: from hormonal biosensors embedded in consumer electronics to telehealth platforms accessible even in low-bandwidth regions. Emerging markets will benefit from femtech’s expansion, as affordable, smartphone-compatible diagnostics empower millions of women, unlocking $1 trillion in untapped economic potential by enabling their full participation in education and the workforce.
“In 2025, femtech will not just enhance healthcare—it will continue to redefine global economic priorities, elevate women’s participation in society and the economy, and improve the lives of all humans. By advancing gender-specific health, femtech will unlock a deeper understanding of the full spectrum of human health, providing insights that benefit all genders. This holistic approach will become the cornerstone of sustainable development and drive unprecedented innovation worldwide, in 2025 and beyond.”
Kanika Mishra Pathak, Lead R&D Director at MHA
“2025 is likely to be a major year for femtech, thanks to a number of changes which are set to bring a wave of fresh investment to the industry. These include £6.1 billion of funding for research in sectors including medical science announced in the budget; the creation of pension ‘megafunds’ designed to boost investment in high growth industries like femtech; and the arrival of a new industrial strategy, which will prioritise growth and investment in industries with untapped potential, a category femtech fits squarely in.
“AI is also accelerating the pace of major technological developments on issues such as breast cancer treatment, IVF embryo assessment and maternal healthcare. We can expect to see significant developments in these areas across the year. The area that is likely to see the biggest advances is wearables, which is becoming a very competitive sector as the market is growing fast and proving particularly popular with women. This is leading several major manufacturers to improve their devices functionality when it comes to women’s health, often through partnerships with and acquisitions of specialist women’s health and menopause technology companies. Expect to see a lot more of this in 2025 as women’s health is put at the front and centre of wearables product development.”
Jennifer Pfau, FemTech Advocate and CEO at pFocus Marketing
“The U.S. femtech industry is poised for transformative growth by 2025, driven by shifting regulatory landscapes. With Republican-led governments often favouring deregulation, the reduced bureaucratic barriers could open doors for innovation across women’s health technology. Startups and established firms alike could benefit from streamlined FDA approval processes and relaxed telemedicine restrictions, expediting the launch of cutting-edge products.
“The easing of restrictions on research and commercialization may also drive breakthroughs in previously underserved areas like menopause management, pelvic health, and endometriosis treatments.
“Deregulation might promote private investment, as venture capitalists (VCs) are drawn to markets with fewer policy-driven bottlenecks. With the continual call for more women-led VCs, the potential influx of capital could accelerate the adoption of AI and data-driven technologies, enabling more personalized health solutions.
“However, the industry will likely face heightened scrutiny from advocacy groups concerned about consumer protection and equitable access. While a Republican-led U.S. government may prioritize deregulation, fostering rapid innovation, this could inspire other nations to reevaluate their policies to remain competitive in the global market. Countries with historically rigid healthcare regulations, such as those in Europe, might begin to adopt more flexible approaches, accelerating approvals for cutting-edge femtech solutions.”
Caroline MacDonald, Founder & CEO of Oggadoon
“Femtech continues to captivate startups and investors alike, showing remarkable growth potential. With increasing waiting lists for medical services, conflicting online advice, and the risk of GP surgeries closing—especially in rural communities— people are becoming more proactive about monitoring their health. More celebrities are opening up about their health journeys on social media, shining a light on the importance of personal well-being. However, a significant challenge remains: most research still overlooks the complexities of the female body
“In 2025, there will be increased resources for managing menopause and perimenopause symptoms, offering holistic approaches to improve quality of life. In the workplace, we are witnessing a growing trend towards support systems for navigating menopause, with technology set to play an increasingly important role in this transformation. Also, demand to monitor general menstrual cycles, and the rise of Gen-Z, who need to understand their hormones more than ever.
“Moreover, maternal care initiatives will expand to provide comprehensive support throughout pregnancy and postpartum periods. This includes access to mental health resources and nutritional guidance aimed at empowering mothers with the knowledge they need. Breastfeeding, sleep deprivation or the fourth trimester is often not discussed with new mothers, and they need to know these are normal experiences and shared by many.
“At Oggadoon we are an all-female team, and are deeply committed to raising awareness about these products and making a meaningful impact. Female health is finally getting the attention it deserves, and the tech companies are maximising this.”
For any questions, comments or features, please contact us directly.
